Download PDF
Thromb Haemost 2002; 88(01): 168-169
DOI: 10.1055/s-0037-1613177
Letters to the Editor
Schattauer GmbH

Low Arginine Intake Reduces Levels of Soluble P-selectin in Hypercholesterolemic Patients

C. Di Febbo
2   Center of Excellence and Department of Medicine and Aging, University “G. D’Annunzio” of Chieti, Chieti, Milan, Italy
,
E. Porreca
2   Center of Excellence and Department of Medicine and Aging, University “G. D’Annunzio” of Chieti, Chieti, Milan, Italy
,
T. Bucciarelli
2   Center of Excellence and Department of Medicine and Aging, University “G. D’Annunzio” of Chieti, Chieti, Milan, Italy
,
M. Milani
1   Center of Excellence and Department of Medicine and Aging, University “G. D’Annunzio” of Chieti, Mipharm, Milan, Italy
,
G. Davì
2   Center of Excellence and Department of Medicine and Aging, University “G. D’Annunzio” of Chieti, Chieti, Milan, Italy
› Author Affiliations
Further Information

Publication History

Received 06 March 2002

Accepted 25 March 2002

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Loscalzo J. What we know and don’t know about L-arginine and NO. Circulation 2000; 101: 2126-9.
    CrossrefPubMedGoogle Scholar
  • 2 Loscalzo J. An experiment of nature: genetic l-arginine deficiency and NO insufficiency. J Clin Invest 2001; 108: 663-4.
    CrossrefPubMedGoogle Scholar
  • 3 Creager MA, Gallagher SI, Girerd XI, Coleman SM, Dzau VI, Cooke IP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. I Clin Invest 1992; 90: 1248-53.
    CrossrefPubMedGoogle Scholar
  • 4 Clarkson P, Adams MR, Powe AJ, Donald AE, Mc RCredie, Robinson I, Mc SNCarthy, Keech A, Celermajer DS, Deanfield IE. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. I Clin Invest 1996; 97: 1989-94.
    CrossrefPubMedGoogle Scholar
  • 5 Chan JR, Boger RH, Bode-Boger SM, Tangphao O, Tsao PS, Blaschke TF, Cooke IP. Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol 2000; 20: 1040-46.
    CrossrefPubMedGoogle Scholar
  • 6 Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, Waklawiw MA, Panza IA, Cannon RO. Oral L-arginine in patients with coronary artery disease on medical management. Circulation 2000; 101: 2160-4.
    CrossrefPubMedGoogle Scholar
  • 7 Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, Waklawiw MA, Panza IA, Cannon RO. Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation on healthy postmenopausal women. I Am Coll Cardiol 2000; 35: 271-6.
    CrossrefPubMedGoogle Scholar
  • 8 Romano M, Mezzetti A, Marulli C, Ciabattoni G, Febo F, Di Ienno S, Roccaforte S, Vigneri S, Nubile G, Milani M, Davi G. Fluvastatin reduces solubile P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide. I Invest Med 2000; 48: 183-9.
    PubMedGoogle Scholar
  • 9 Whiss PA, Andersson RG, Srinivas U. Modulation of P-selectin expression on isolated human platelets by an NO donor assessed by a novel ELISA application. I Immunol Methods 1997; 200: 135-43.
    PubMedGoogle Scholar
  • 10 Davi G, Romano M, Mezzetti A, Procopio A, Iacobelli S, Antidormi T, Bucciarelli T, Alessandrini P, Cuccurullo F, Bittolo GBon. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 1998; 97: 953-7.
    CrossrefPubMedGoogle Scholar
  • 11 Furie B, Furie BC. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocyte: role of P-selectin and the P-selectin ligand, PSGL-1. Thromb Haemost 1995; 74: 224-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Cooke IP, Tsao PS. Arginine: a new therapy for atherosclerosis?. Circulation 1997; 95: 311-2.
    CrossrefPubMedGoogle Scholar
  • 13 Loscalzo I. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001; 88: 756-62.
    CrossrefPubMedGoogle Scholar